Dan Douer

11.5k total citations · 1 hit paper
192 papers, 5.7k citations indexed

About

Dan Douer is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Dan Douer has authored 192 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Hematology, 77 papers in Public Health, Environmental and Occupational Health and 76 papers in Molecular Biology. Recurrent topics in Dan Douer's work include Acute Lymphoblastic Leukemia research (77 papers), Acute Myeloid Leukemia Research (72 papers) and Retinoids in leukemia and cellular processes (45 papers). Dan Douer is often cited by papers focused on Acute Lymphoblastic Leukemia research (77 papers), Acute Myeloid Leukemia Research (72 papers) and Retinoids in leukemia and cellular processes (45 papers). Dan Douer collaborates with scholars based in United States, Israel and Canada. Dan Douer's co-authors include Martin S. Tallman, H. Phillip Koeffler, Eric L. Chang, Richard L. Bakst, Joachim Yahalom, Jae H. Park, Hagop M. Kantarjian, Ibrahim Aldoss, David A. Scheinberg and H P Koeffler and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Journal of Clinical Investigation.

In The Last Decade

Dan Douer

184 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

United States Multicenter Study of Arsenic Trioxide in Relapsed Acute Promyelocytic Leukemia

2001 632 citations Dan Douer, Martin S. Tallman et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Dan Douer

Since Specialization

Citations

This map shows the geographic impact of Dan Douer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Douer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Douer more than expected).

Fields of papers citing papers by Dan Douer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Douer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Douer. The network helps show where Dan Douer may publish in the future.

Co-authorship network of co-authors of Dan Douer

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Douer. A scholar is included among the top collaborators of Dan Douer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Douer. Dan Douer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Shorter long-term post-transplant life expectancy may be due to prior chemotherapy for the underlying disease: analysis of 3012 patients with acute myeloid leukemia enrolled on 9 consecutive ECOG-ACRIN trials 2024 ·Bone Marrow Transplantation ·Chezi Ganzel, Yihua Wang, (unknown), Zijie Sun, Jacob M. Rowe, Hugo F. Fernández, Elisabeth Paietta, S. M. Luger, Hillard M. Lazarus, Larry D. Cripe, Dan Douer, Peter H. Wiernik, Martin S. Tallman, Mark R. Litzow	1
2	Immunophenotype of acute lymphoblastic leukemia in minorities‐ analysis from the SEER database 2021 ·Hematological Oncology ·(unknown), (unknown), Rebecca A. Nelson, Ibrahim Aldoss, Vinod Pullarkat, Eduardo Magalhães Rego, Guido Marcucci, Dan Douer	3
3	Optimizing use of L-asparaginase–based treatment of adults with acute lymphoblastic leukemia 2021 ·Blood Reviews ·Dan Douer, Nicola Gökbuget, Wendy Stock, Nicolas Boissel	19
4	Pediatric-inspired chemotherapy incorporating pegaspargase is safe and results in high rates of minimal residual disease negativity in adults up to age 60 with Philadelphia chromosome-negative acute lymphoblastic leukemia 2020 ·Haematologica ·Mark B. Geyer, Ellen K. Ritchie, Arati V. Rao, Shreya Vemuri, Jessica Flynn, Meier Hsu, Sean M. Devlin, Mikhail Roshal, Qi Gao, (unknown), (unknown), P. Maslak, Martin S. Tallman, Dan Douer, Jae H. Park	29
5	High-Dose Vincristine Sulfate Liposome Injection, for Advanced, Relapsed, or Refractory Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in an Adolescent and Young Adult Subgroup of a Phase 2 Clinical Trial 2018 ·Journal of Adolescent and Young Adult Oncology ·Gary J. Schiller, Lloyd E. Damon, Steven Coutré, (unknown), Gajanan Bhat, Dan Douer	22
6	A Pediatric-Inspired Regimen Containing Multiple Doses of Intravenous Pegylated Asparaginase Appears Safe and Effective in Newly Diagnosed Adult Patients with Ph-Negative Acute Lymphoblastic Leukemia in Adults up to Age 60: Results of a Multi-Center Phase II Clinical Trial 2016 ·Blood ·Jae H. Park, Ellen K. Ritchie, Arati V. Rao, Sean M. Devlin, Meier Hsu, (unknown), Bridget A. O’Donnell, (unknown), (unknown), Martin S. Tallman, Dan Douer	5
7	A Woman With CD19-Positive, B-Cell ALL. 2016 ·Dan Douer	2
8	Extramedullary Disease in Adult Acute Myeloid Leukemia Is Common but Lacks Independent Significance: Analysis of Patients in ECOG-ACRIN Cancer Research Group Trials, 1980-2008 2016 ·Journal of Clinical Oncology ·Chezi Ganzel, Judith Manola, Dan Douer, Jacob M. Rowe, Hugo F. Fernández, Elisabeth Paietta, Mark R. Litzow, Ju-Whei Lee, Selina M. Luger, Hillard M. Lazarus, Larry D. Cripe, Peter H. Wiernik, Martin S. Tallman	85
9	Postconsolidation Maintenance and Monitoring in Patients With Acute Promyelocytic Leukemia 2013 ·Journal of the National Comprehensive Cancer Network ·Chezi Ganzel, Dan Douer, Martin S. Tallman	3
10	Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid 2011 ·Blood ·Jae H. Park, Baozhen Qiao, Katherine S. Panageas, Maria J. Schymura, Joseph G. Jurcic, Todd Rosenblat, Jessica K. Altman, Dan Douer, Jacob M. Rowe, Martin S. Tallman	279
11	Curing All Patients with Acute Promyelocytic Leukemia: Are We There Yet? 2011 ·Hematology/Oncology Clinics of North America ·Muhamed Baljević, Jae H. Park, Eytan M. Stein, Dan Douer, Jessica K. Altman, Martin S. Tallman	15
12	Is asparaginase a critical component in the treatment of acute lymphoblastic leukemia? 2008 ·Best Practice & Research Clinical Haematology ·Dan Douer	30
13	The epidemiology of acute promyelocytic leukaemia 2003 ·Best Practice & Research Clinical Haematology ·Dan Douer	58
14	Acute promyelocytic leukemia 2000 ·Current Treatment Options in Oncology ·Dan Douer	9
15	Transcription therapy for acute promyelocytic leukaemia 2000 ·Expert Opinion on Investigational Drugs ·Dan Douer	5
16	Comparison of Progenitor Cell Content in Sequential Peripheral Blood Progenitor Collections after Mobilization with Chemotherapy and Granulocyte Macrophage Colony- Stimulating Factor 1998 ·Acta Haematologica ·Eric L. Chang, John D. Parker, Susan Groshen, Kristy Watkins, Dan Douer	5
17	Comparative study of infections complications of different types of chronic central venous access devices 1994 ·Cancer ·Yi‐Kong Keung, Kristy Watkins, (unknown), Susan Groshen, Howard Silberman, Dan Douer	38
18	Tranexamic acid therapy in acute myeloid leukemia: Possible reduction of platelet transfusions 1990 ·European Journal Of Haematology ·Isaac Ben‐Bassat, Dan Douer, Bracha Ramot	24
19	Methimazole‐induced agranulocytosis: Growth inhibition of myeloid progenitor cells by the patient's serum 1988 ·European Journal Of Haematology ·Dan Douer, Zemach Eisenstein	24
20	Serum immunoglobulin levels in patients with Hodgkin's disease: relation to disease activity and clinical stage. 1978 ·PubMed ·Dan Douer, (unknown), E Kessler, (unknown), Kenan Zhang	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact